India's domestic pharmaceutical market is estimated at US$ 42 billion in 2021 and likely to reach US$ 65 billion by 2024 and further expand to ~US$ 120-130 billion by 2030. The 'pharmacy of the world' holds the potential to alter the quality of life in the world with its large talent pool of researchers, engineers, and doctors. When put to the test under the pandemic, the domestic industry worked closely with the global ecosystem to develop therapies and vaccines to control the spread of the deadly virus. Forecasting the future of the healthcare and pharma industry, Simon Gallagher, General Manager (Interim), Takeda India, said that the same truly global spirit of collaborations and partnerships should guide the future of the pharma industry that can change the healthcare infrastructure of the entire nation.
As the year 2022 unfolds, the industry can be seen realigning efforts towards developing cures and treatments for other diseases. Discourse on prioritizing treatment for rare diseases has gained prominence and is expected to develop further in the forthcoming years.
Commenting on the upcoming trends in the pharma industry, Simon Gallagher, (Interim) General Manager at Takeda, India, said,"The pharmaceutical sector became more focused on innovation and technology over the past two years of change. A huge phygital (physical + digital) transition was witnessed with the emergence of a hybrid model of engagement with Health Care Professionals. In the coming years, the industry is expected to level up digital capabilities and technology adoption to create personalized tools for patient care. The opportunity lies in improving virtual tools to build immersive patient experiences. The future of pharmaceuticals is dependent on industry research and development, not just to combat COVID-19 but also to combat other diseases. The power of innovation shall help the industry unlock ways to make quality care more accessible and shall pave the way for better medications and pharmaceutical instruments."
An emerging focus can be seen towards leveraging data and digital across all levels to understand patient journeys better and simplify the treatment processes. Against traditional medicine, the coming years are expected to witness investments in cell and gene therapies to change the course of acquired human diseases.
Despite numerous upcoming therapies, the past two years have taught us that the key to advancing healthcare in India would remain to make quality care accessible to the underserved communities. The years to come can thus see the pharmaceutical companies working closely with the public sector to bridge infrastructural gaps to enhance timely diagnosis through widespread awareness, collaborating to create a mindset for research, and bringing in innovations to fulfil the healthcare needs.
Gurugram, India – October 11, 2023: Samsung announced exciting offers
Bangalore, 10th October 2023: The Nokia G42 5G (16GB+256G
Bengaluru, October 10, 2023 IN-SPACe (Indian National Space Promotion and
New Delhi, October 3, India- Philips India announces an exciting co
 (1)_1713611592.jpg)
Through this exciting initiative, the brand aims to emerge as the go-to purveyor of authentic Chinese in India
New D
Jaipur, 18 April: Students of Jaipur have recently shown their remarkable achievement in the UPSC Civil Services Examination-
· Technopark-based Lifology holds conversation on IER 2024
Thiru
Business / 20-04-2024
MasterChow taps renowned Chef Ranveer Brar as its Brand Ambassador to champion Asli ChineseSports / 20-04-2024
Aditya Mehta Foundation's para cyclists Jyoti Gaderiya & Arshad Shaik achieve top world rankings in the latest Track Para Rankings, bringing pride to India!Business / 18-04-2024
STUDENTS OF JAIPUR'S JAYSHREE PERIWAL HIGH SCHOOL BRING LAURELS TO SCHOOL IN UPSCBusiness / 18-04-2024
India Employment Report pitches for policy to promote jobsBusiness / 18-04-2024
The EMAK Festoon Silent Heroes Awards-24 Concludes at Le Méridien, KochiPelikken © Copyright 2022, All Rights Reserved
